Related Experiment Video
Updated: Jul 2, 2026
10:13
Micropatterned Surfaces to Study Hyaluronic Acid Interactions with Cancer Cells
Published on: December 22, 2010
Hyaluronan oligosaccharides as a potential anticancer therapeutic
Bryan P Toole1, Shibnath Ghatak, Suniti Misra
1Department of Cell Biology and Anatomy, Medical University of South Carolina, 173 Ashley Avenue, Charleston, South Carolina 29425, USA. toolebp@musc.edu
Current Pharmaceutical Biotechnology
|August 12, 2008
Summary
Small hyaluronan (HA) oligosaccharides selectively kill cancer cells by inducing apoptosis, sparing normal cells. This discovery offers a promising new avenue for developing novel anticancer therapeutics, even for chemoresistant cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Hyaluronan (HA) is a polysaccharide with diverse biological functions.
- The biological activity of HA is dependent on its polymer size.
- Cancer cells often exhibit altered HA metabolism.
Purpose of the Study:
- To investigate the differential effects of HA polymer sizes on cancer cells.
- To explore the potential of small HA oligosaccharides as anticancer agents.
- To determine if HA oligosaccharides can overcome chemoresistance.
Main Methods:
- Treatment of various cancer cell lines and normal cells with different sizes of HA.
- Assessment of cell viability and apoptosis induction.
- Evaluation of chemoresistant cell response to co-treatment with HA oligosaccharides.
Main Results:
- Small HA oligosaccharides (6-18 sugar units) induced apoptosis in multiple cancer cell types.
- Large HA polymers did not exhibit significant cytotoxic effects on cancer cells.
- Normal cells remained unaffected by small HA oligosaccharides.
- Co-treatment with HA oligosaccharides sensitized chemoresistant cancer cells to chemotherapy.
Conclusions:
- Small HA oligosaccharides possess selective anticancer properties by triggering apoptosis.
- HA oligosaccharides represent a novel therapeutic strategy for cancer treatment.
- This approach holds potential for overcoming drug resistance in cancer therapy.
More Related Videos
Related Concept Videos
01:23Glycosaminoglycans
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...